Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
98.22
+1.95 (2.03%)
Dec 20, 2024, 4:00 PM EST - Market closed
Merit Medical Systems Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for MMSI stock have an average target of 105.6, with a low estimate of 87 and a high estimate of 127. The average target predicts an increase of 7.51% from the current stock price of 98.22.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MMSI stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Hold | 2 | 1 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 9 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $103 → $120 | Hold → Buy | Upgrades | $103 → $120 | +22.17% | Dec 11, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $125 → $127 | Strong Buy | Maintains | $125 → $127 | +29.30% | Dec 9, 2024 |
| Needham | Needham | Strong Buy Reiterates $109 | Strong Buy | Reiterates | $109 | +10.98% | Oct 31, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $114 | Buy | Maintains | $114 | +16.07% | Oct 31, 2024 |
| Baird | Baird | Buy Maintains $107 → $109 | Buy | Maintains | $107 → $109 | +10.98% | Oct 31, 2024 |
Financial Forecast
Revenue This Year
1.38B
from 1.26B
Increased by 9.36%
Revenue Next Year
1.50B
from 1.38B
Increased by 9.02%
EPS This Year
3.42
from 1.62
Increased by 111.14%
EPS Next Year
3.79
from 3.42
Increased by 10.77%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.4B | 1.6B | 1.7B | |||
| Avg | 1.4B | 1.5B | 1.6B | |||
| Low | 1.3B | 1.4B | 1.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 12.7% | 13.2% | 10.9% | |||
| Avg | 9.4% | 9.0% | 5.4% | |||
| Low | 4.9% | 3.7% | -1.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 3.53 | 3.99 | 4.46 | |||
| Avg | 3.42 | 3.79 | 4.20 | |||
| Low | 3.27 | 3.44 | 3.85 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 117.8% | 16.7% | 17.8% | |||
| Avg | 111.1% | 10.8% | 10.8% | |||
| Low | 102.0% | 0.6% | 1.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.